Global Blockchain in Pharmaceutical Supply Chain Management Market Research Report: Information by Application (Product Traceability, Risk and Compliance Management, Payment & Settlement, Others), End User (Manufacturers, Distributors, Healthcare Providers) and Region - Global Forecast till 2027
ID: MRFR/HC/6537-HCR | February 2021 | Region: Global | 90 pages
Market Scenario
The Global Blockchain in Pharmaceutical Supply Chain Management Market is expected to register a CAGR of 22.5% during the forecast period of 2019 to 2024.
A blockchain solution can make a substantive difference to the pharmaceutical supply chain. At every stage of the supply chain process, barcodes would be scanned and recorded onto a blockchain ledger system which, in sequence, records and creates an audit trail of the drug journey. Sensors can also be combined into the supply chain, with temperature or humidity being noted onto the ledger system. This is most important for drugs requiring fridge storage, such as insulin or expensive, specially manufactured medicines.
Furthermore, through the use of blockchain, the supply chain process of the drugs can become more secure and streamlined. Every delivery can be tracked, with the delivery driver traced through biometric measures. Every checkpoint concerning the drugs supply is recorded and traced via biometric measures, 2d barcode scans, or sensor technology. As the drug is tracked from its manufacturing unit to the patient, the whole of the drug supply chain becomes seamless, precise, audited, and safe.
Segmentation
The global blockchain in pharmaceutical supply chain management is segmented on the basis of application, end user, and region.
On the basis of application, the global blockchain in pharmaceutical supply chain management market is segmented into product traceability, risk and compliance management, payment & settlement, others. The market by end user is segmented into manufacturers, distributors, healthcare providers
Key Players
Some of the key players in the Global Blockchain In Pharmaceutical Supply Chain Management Market are IBM, Microsoft, SAP SE, Oracle, Tibco Software, Auxesis Group, Omnichain, Vechain Foundation, Chainvine, Applied Blockchain, AWS, Huawei, Guardtime, BTL Group, Bitfury, Digital Treasury Corporation, Blockverify, Nodalblock, Peer Ledger, and others.
Regional Market Summary
Global Blockchain in Pharmaceutical Supply Chain Management Market Share (%), by Region, 2018 
Sources: United Census Bureau, Indian Brand Equity Foundation, International Journal of Women's Health, Annual Reports, Press Release, White Paper, and Company Presentation
The global blockchain in pharmaceutical supply chain management market is segmented on the basis of regions: Americas, Europe, Asia-Pacific, and the Middle East & Asia. The Americas account for the major share of the market owing to the well-developed technology, high healthcare expenditure, and the presence of the major pharmaceutical players. Europe accounted for the second largest market, which is followed by Asia-Pacific. Well-developed healthcare infrastructure and higher healthcare funds have driven the European blockchain in pharmaceutical supply chain management market. Asia-Pacific is the fastest growing blockchain in pharmaceutical supply chain management market. Rapidly changing healthcare sector, and the presence of huge opportunities for the development of this market have paved the way for market growth. However, the Middle East and Africa holds the least share in the global blockchain in pharmaceutical supply chain management market. The presence of poor economies and low per capita income, especially within Africa, restrains the growth within the region. A majority of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare for healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.
Research Methodology
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
- Primary Research
- Extensive primary research was conducted to gain a deeper insight into the market and industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
- Secondary Research
- Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the blockchain in pharmaceutical supply chain management solutions market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.
Market Segmentation
Global Blockchain in Pharmaceutical Supply Chain Management Market, by Application
- Product Traceability
- Risk and Compliance Management
- Payment & Settlement
- Others
Global Blockchain in Pharmaceutical Supply Chain Management Market, by End User
- Manufacturers
- Distributors
- Healthcare Providers
Intended Audience
- Healthcare Providers
- Healthcare IT Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Frequently Asked Questions (FAQ) :
Blockchain in pharmaceutical supply chain management market is projected to grow at a 22.5% CAGR between 2019-2024.
The Americas is expected to dominate the blockchain in pharmaceutical supply chain management market.
End users of the blockchain in pharmaceutical supply chain management market include healthcare providers, distributors, and manufacturers.
The blockchain in pharmaceutical supply chain management is widely used in payment and settlement, product traceability, and others.
Some of the key strategies adopted by key players operating in the blockchain in pharmaceutical supply chain management market include expansion, product development, acquisition, and innovation.
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Blockchain in Pharmaceutical Supply Chain Management Market, by Application
6.1 Overview
6.2 Product Traceability
6.3 Risk and Compliance Management
6.4 Payment & Settlement
Chapter 7. Global Blockchain in Pharmaceutical Supply Chain Management Market, by End User
7.1 Overview
7.2 Manufacturers
7.3 Distributors
7.4 Healthcare Providers
Chapter 8. Global Blockchain in Pharmaceutical Supply Chain Management Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 Latin America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
Chapter 10. Company Profiles
10.1 IBM
10.1.1 Company Overview
10.1.2 Services Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Microsoft
10.3 SAP SE
10.4 Oracle
10.5 Tibco Software
10.6 Auxesis Group
10.7 OMNICHAIN
10.8 Vechain Foundation
10.10 Chainvine
10.10 Applied Blockchain
10.11 AWS
10.12 Huawei
10.13 Guardtime
10.14 BTL Group
10.15 Bitfury
10.16 Digital Treasury Corporation
10.17 Blockverify
10.18 Nodalblock
10.110 Peer Ledger
10.20 Others
Chapter 11 Appendix
LIST OF TABLES
TABLE 1 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET ESTIMATES AND FORECAST, 2020-2027(USD MILLION)
TABLE 3 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 4 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 5 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 6 NORTH AMERICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 7 NORTH AMERICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 8 NORTH AMERICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 9 US: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 10 US: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 11 US: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 12 CANADA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 13 CANADA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 14 CANADA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 15 SOUTH AMERICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 16 SOUTH AMERICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 17 SOUTH AMERICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 18 EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 19 EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 20 EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 21 WESTERN EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 22 WESTERN EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 23 WESTERN EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 24 EASTERN EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 25 EASTERN EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 26 EASTERN EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 27 ASIA-PACIFIC: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 28 ASIA-PACIFIC: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 29 ASIA-PACIFIC: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2020-2027(USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 SEGMENTATION FOR GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 4 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 5 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2020 (%)
FIGURE 6 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 NORTH AMERICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 8 EUROPE: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 9 ASIA-PACIFIC: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 MIDDLE EAST & AFRICA: BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 11 GLOBAL BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 12 IBM: KEY FINANCIALS
FIGURE 13 IBM: SEGMENTAL REVENUE
FIGURE 14 IBM: GEOGRAPHICAL REVENUE
FIGURE 15 MICROSOFT: KEY FINANCIALS
FIGURE 16 MICROSOFT: SEGMENTAL REVENUE
FIGURE 17 MICROSOFT: GEOGRAPHICAL REVENUE
FIGURE 18 SAP SE: KEY FINANCIALS
FIGURE 19 SAP SE: SEGMENTAL REVENUE
FIGURE 20 SAP SE: GEOGRAPHICAL REVENUE
FIGURE 21 ORACLE: KEY FINANCIALS
FIGURE 22 ORACLE: SEGMENTAL REVENUE
FIGURE 23 ORACLE: GEOGRAPHICAL REVENUE
FIGURE 24 TIBCO SOFTWARE: KEY FINANCIALS
FIGURE 25 TIBCO SOFTWARE: SEGMENTAL REVENUE
FIGURE 26 TIBCO SOFTWARE: GEOGRAPHICAL REVENUE
FIGURE 27 AUXESIS GROUP: KEY FINANCIALS
FIGURE 28 AUXESIS GROUP: SEGMENTAL REVENUE
FIGURE 29 AUXESIS GROUP: GEOGRAPHICAL REVENUE
FIGURE 30 OMNICHAIN USA, INC: KEY FINANCIALS
FIGURE 31 OMNICHAIN USA, INC: SEGMENTAL REVENUE
FIGURE 32 OMNICHAIN USA, INC: GEOGRAPHICAL REVENUE
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.